Previous 10 |
BioTelemetry ( BEAT +15.2% ) is up on almost double normal volume after posting Q3 results after the close yesterday. Highlights: More news on: BioTelemetry, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, Read more ...
BioTelemetry, Inc. (BEAT) Q3 2018 Earnings Conference Call October 30, 2018, 05:00 PM ET Executives Joseph Capper - President & CEO Heather Getz - CFO Analysts Bruce Nudell - SunTrust Brooks O'Neil - Lake Street Capital Marco Rodriguez - Stonegate Capital Markets De...
BioTelemetry (NASDAQ: BEAT ): Q3 Non-GAAP EPS of $0.53 beats by $0.21 ; GAAP EPS of $0.45 beats by $0.26 . More news on: BioTelemetry, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Company’s Results Exceed Expectations Company Raises Full-Year Guidance MALVERN, Pa., Oct. 30, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote and wireless medical technology company focused on the delivery of health information to improve q...
ACGL , AEGN , AFG , AINV , AMGN , APAM , APC , BAND , BEAT , BGS , BHE , BIDU , BJRI , BXP , CAI , CAKE , CHRW , CLVS , CONE , CRAY , CW , CXO , DDD , DENN , EA , EBAY , EIX , ESIO , EVTC , EXAS , EXR , FB , FEYE , FLT , GNW , H , HABT , HCLP , HLF , ...
News, Short Squeeze, Breakout and More Instantly...
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has been added to the Russell Microcap(R) Index. The move was effective after market close on June 28, 2024, and is part of FTSE Russell’s annual reconst...
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced that it has been added to the Russell Microcap® Index effective after the market close on June 28, 2024 as part of FTSE Russell...
HeartBeam (NASDAQ: BEAT) , a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced the results of a new study demonstrating that HeartBeam AI combined with vectorcardiography (“VCG”) outperformed an expert panel o...